Brain study offers Alzheimer’s hope

Scientists analysed the way brain cells communicate at times of peak activity - such as the creation of new memories or in epileptic seizures - when electrical signalling by the brain's neurons is increased. This raises the possibility that drugs could be developed to block the effect of this enzyme, increasing chemical messaging between brain cells, researchers say. Conversely, researchers also say that drugs could also be developed to boost the effect of the enzyme, slowing brain activity in epilepsy patients and reducing the effects of their seizures. This study shows that GSK3 plays a crucial part in controlling brain function during peak activity. The development of drugs to act on the enzyme could make a real difference to the lives of people with brain